The data published in NEJM highlight the positive Phase 3 VALIANT results at Week 26, which were consistent across adolescent and adult patients with C3G and primary IC-MPGN, including patients with ...
The George Soros protege has generated legendary returns for decades, so it's hard not to take stock in where Druckenmiller ...